Yukon Medical

Yukon Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Yukon Medical is a private, commercial-stage medical device company headquartered in Durham, North Carolina, USA. It develops and markets specialized devices for medication preparation and delivery, with a core portfolio including the Vialok vial access system and the Arisure closed system transfer device (CSTD). The company serves clinicians, pharmaceutical companies, and diagnostic firms, emphasizing safety, innovation, and customer-focused design. It is ISO13485 certified and partners with leading medtech and pharmaceutical companies.

OncologyInfectious DiseaseAutoimmuneGeneral Healthcare

Technology Platform

Patented mechanical and fluidic engineering platform for secure vial access (Vialok) and closed-system hazardous drug transfer (Arisure CSTD), featuring locking connectors and integrated filtration.

Opportunities

Growing regulatory emphasis on healthcare worker safety (e.g., USP <800>) drives adoption of Closed System Transfer Devices (CSTDs).
Partnering with pharmaceutical companies for integrated drug-device combinations offers a high-value, recurring revenue stream.
Expansion into international markets presents a significant growth avenue as safety standards evolve globally.

Risk Factors

Intense competition from larger, established medtech companies could lead to price pressure and commoditization.
Adoption is sensitive to hospital budgets and inconsistent enforcement of safety guidelines, impacting sales cycles.
Dependency on key manufacturing partners or a few large distribution/pharma partners creates concentration risk.

Competitive Landscape

Yukon operates in the competitive vial access and Closed System Transfer Device (CSTD) market, competing directly with large global medtech players like BD (BD PhaSeal) and ICU Medical (ChemoClave). The landscape is characterized by competition on clinical proof of containment, ease of use, cost, and the strength of partnerships with pharmaceutical manufacturers.